Goal: To illustrate how the successive use of a continuous quality improvement program for maintaining and improving an intravenous iron and anemia management protocol can improve patient outcomes.
Describe the revision of an anemia management protocol in the context of an established CQI process.
Explain how evidence-based literature on erythropoietin-stimulating agents and IV iron therapy should be used to drive CQI revision.
Evaluate the effects on patient outcomes of a revised anemia management protocol using the CQI process.
Acknowledgments: The author acknowledges the assistance of David S. MacDougall and Liz Turrin in the preparation of this manuscript. Writing assistance was provided with support from Watson.
Disclosure Statement: The author reported that she is on the Watson Pharmaceuticals Speakers' Bureau.
Note: This article is supported by a financial grant from Watson Pharma, Inc. This article has undergone peer review. The information in this article does not necessarily reflect the opinions of ANNA or the sponsor.